The Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR) 2019 Draft Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease.
Lyme Disease Guidelines: Devoted to transparency in Lyme diagnosis and treatment Guidelines
Historically, Medical Guidelines have been established by the Institute of Medicine (IOM) and posted on the National Clearing House for Guidelines website (Guidelines.gov). Guidelines are generally written by Medical Societies and are not to be confused with Standards of Care. They are designed to facilitate patient care, but not to dictate the care of any given patient in the Community. The Centers for Disease Control (CDC) also maintains guidelines, and these are designed for disease surveillance and public health purposes.
In 2006 the Infectious Disease Society of America (IDSA) published guidelines for Lyme Disease. In 2015 another medical society, The International Lyme and Associated Disease Society (ILADS) did the same. IDSA guidelines fell short of the IOM standards and were removed, but the ILADS guidelines remained. Currently, the ILADS guidelines are the only ones meeting IOM standards. On June 26, 2019, IDSA published a proposed set of guidelines. They are mandated to provide a 45-day period (ending August 10, 2019) for comments from the public before officially releasing them.
Go here to read IDSA guidelines and supplementary material: https://www.lymediseaseguidelines.org/guideline-links/
Go here to submit comments on guidelines: https://www.lymediseaseguidelines.org/contact-us/
Go here for “official” public comment on guidelines: https://www.surveymonkey.com/r/7HG3XCQ